Picrocrocin

Picrocrocin is a monoterpene glycoside found in saffron that serves as a precursor to the aromatic compound safranal. In-vitro studies suggest it may inhibit adenocarcinoma and hepatocarcinoma cell proliferation through cellular pathway modulation.

Origin & History

Picrocrocin is a monoterpene glycoside isolated from saffron, the dried stigmas of Crocus sativus L. It is primarily responsible for saffron's characteristic bitter taste and is a precursor to safranal, contributing to saffron's aroma.

Historical & Cultural Context

The research does not provide specific information about picrocrocin's traditional or historical use in medicinal systems. Further investigation into traditional medicine sources would be required.

Health Benefits

• May reduce proliferation of adenocarcinoma and hepatocarcinoma cells (in-vitro evidence)[2]
• Acts as a molecular marker of authentic saffron due to its unique flavor profile[2]
• Precursor to safranal, which is known for its aromatic properties[3]
• Slightly soluble in water and acetonitrile, indicating potential for formulation flexibility[2][5]
• Soluble in methanol and alcohol, facilitating diverse extraction methods[2][4]

How It Works

Picrocrocin undergoes enzymatic hydrolysis to produce safranal, which contributes to saffron's distinctive aroma and potential bioactivity. The compound appears to interfere with cancer cell proliferation pathways, though the specific molecular targets and receptor interactions remain under investigation. Its glycosidic structure allows for controlled release of active metabolites during digestion.

Scientific Research

The provided research lacks specific human clinical trials or meta-analyses with PMIDs. Existing evidence is primarily in-vitro or preliminary in nature, focusing on picrocrocin's cellular effects.

Clinical Summary

Current evidence for picrocrocin is limited to in-vitro laboratory studies demonstrating anti-proliferative effects against adenocarcinoma and hepatocarcinoma cell lines. No human clinical trials have specifically evaluated picrocrocin as an isolated compound. Most research focuses on saffron extracts containing picrocrocin alongside other bioactive compounds like crocin and safranal. The compound's primary documented role is as a chemical marker for saffron authenticity rather than therapeutic applications.

Nutritional Profile

Picrocrocin (chemical formula C₁₆H₂₆O₇, molecular weight ~346.37 g/mol) is a monoterpene glycoside and the principal bitter-tasting compound in saffron (Crocus sativus L. stigmas). It is not a macronutrient or micronutrient source itself but rather a specialized bioactive secondary metabolite. Key details: • Typically constitutes approximately 1–13% (w/w dry basis) of high-quality saffron stigmas, with ISO 3632 grading requiring a minimum absorbance value (at 257 nm) of 70 for Category I saffron. • Structurally, it is the β-D-glucopyranoside of hydroxyl-β-cyclocitral (HTCC); upon enzymatic or thermal hydrolysis it yields glucose and safranal (the primary volatile aroma compound of saffron). • Contains no appreciable vitamins, minerals, protein, fat, or dietary fiber on its own. • As a glycoside, it possesses moderate water solubility (~slightly soluble), good solubility in methanol and ethanol, and slight solubility in acetonitrile, which influences its extraction and bioavailability. • Bioavailability: Limited direct human pharmacokinetic data exist; however, its glycosidic bond is expected to be cleaved by gut β-glucosidases, releasing the aglycone HTCC/safranal, which may be more readily absorbed. Oral bioavailability is presumed moderate based on its hydrophilic sugar moiety facilitating intestinal uptake, though first-pass metabolism likely converts much of it to safranal and related metabolites. • Co-occurring bioactives in saffron that are nutritionally relevant include crocin (water-soluble carotenoid glycoside, ~6–16% dry weight), crocetin (carotenoid aglycone), safranal (~0.5–1% in dried saffron), riboflavin (vitamin B₂, ~0.1 mg per gram of saffron), and trace minerals (manganese, iron, magnesium, potassium). • Picrocrocin itself has demonstrated in-vitro cytotoxic activity against adenocarcinoma and hepatocarcinoma cell lines, suggesting anticancer bioactive potential, though in-vivo human evidence remains limited. • Caloric contribution is negligible given the extremely small quantities consumed in typical saffron usage (30–250 mg saffron per serving).

Preparation & Dosage

The research does not provide clinically studied dosage ranges for picrocrocin. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Safranal, Crocin, Curcumin, Piperine, Resveratrol

Safety & Interactions

Safety data for isolated picrocrocin is limited, though saffron containing picrocrocin is generally recognized as safe when used as a spice. No specific drug interactions have been documented for picrocrocin alone. Pregnant women should avoid therapeutic doses of saffron-derived compounds due to potential uterine stimulant effects. Individuals with bipolar disorder should exercise caution, as saffron compounds may affect mood regulation.